Commentary - (2016) Volume 1, Issue 1
Citation:
Aspeslagh S, Marabelle A (2016) Defining the Role of a Novel Immune Checkpoint Modulator: Anti-OX40. J Cancer Clin Trials 1:103.
© 2016 Aspeslagh S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Journal of Cancer Clinical Trials received 95 citations as per Google Scholar report